Security Purchase Plan Open
Released
Released
Announcement PDF
Enlitic, Inc.
1635 Foxtrail Drive, Suite 111A
Loveland, CO 80538
www.enlitic.com
7 August 2026
Security Purchase Plan Open
Enlitic, Inc. (ASX: ENL) (“Enlitic” or the “Company”) announced on Friday, 3 July 2026 that it had received
binding commitments to raise approximately A$15 million (before costs) in a placement of new fully paid
CHESS Depositary Interests (“CDIs”) (“New CDIs”) in the Company at a price of A$0.004 per New CDI
(“Placement Offer Price”), subject to: (i) shareholder approval for the purposes of ASX Listing Rule 7.1 and ASX
Listing Rule 10.11 (in respect of proposed Director participation); and (ii) conversion of its then existing
8,000,000 secured convertible notes into CDIs (“Conditional Placement”). The Company also announced that,
subject to obtaining any necessary ASX waivers and shareholder approval the Company will offer Eligible CDI
Holders the opportunity to participate in a security purchase plan (“SPP”, together with the Conditional
Placement, the “Offer”) which targets to raise up to approximately A$1 million (before costs). On Tuesday, 14
July 2026 Enlitic provided the market with an update in respect of the SPP.
On Wednesday, 29 July 2026, Enlitic shareholders approved the Offer (among other items) at the Company’s
Extraordinary General (Special) Meeting.
Proceeds from the Condi onal Placement are intended to be used for con nued commercialisa on, scale-up
of sales and marke ng, working capital and balance sheet support (refer to the Company’s announcement and
Investor Presenta on provided to the ASX on Friday, 3 July 2026 for further informa on).
Funds raised from the SPP will be used for general corporate and working capital purposes and flexibility in
implementing Enlitic’s strategic commercial objectives (refer to the Company’s announcement and Investor
Presenta on provided to the ASX on Friday, 3 July 2026 for further informa on).
The SPP will open at 9.00am (Melbourne time) today, Friday, 7 August 2026, to Eligible CDI Holders, being
persons who were registered holders of CDIs in Enlitic at 7.00pm (Melbourne time) on Thursday, 2 July 2026,
with a registered address in either Australia or New Zealand at that time as shown on the CDI register (and who
meet certain other eligibility criteria), to apply for up to $30,000 worth of New CDIs at the SPP Offer Price.
Participation in the SPP is optional.
The SPP Offer Price per New CDI will be the lower of: (i) A$0.004 (being the same as the Placement Offer Price);
and (ii) a 2.5% discount to the volume weighted average price of CDIs traded on ASX during the five trading
days up to the closing date of the SPP, rounded to the nearest A$0.001. The SPP is being offered to Eligible CDI
Holders to extend an opportunity to invest on terms no less favourable as the institutional and sophisticated
investors who participated in the Conditional Placement. The SPP will enable Eligible CDI Holders, irrespective
of the size of their holding, to apply to participate in the capital raising at the SPP Offer Price, and not incur any
brokerage or transaction costs. Once issued, New CDIs issued under the SPP will rank equally with existing CDIs
in Enlitic.
Enlitic reserves the right to scale back applications at its absolute discretion.
SPP booklet
The SPP is subject to the terms and condi ons set out in the SPP booklet (a copy of which is a ached). Eligible
CDI Holders who have provided an email address will be sent an email communica on with details of how to
obtain a copy of the SPP booklet and their personalised applica on form (samples of which are a ached).
Eligible CDI Holders who have not provided an email address will be sent an SPP offer le er (a sample of which
is a ached) via post with details of how to obtain a copy of the SPP booklet and their personalised applica on
form. The SPP booklet and personalised applica on forms are also available at:
h ps://events.miraqle.com/enl-offer.
Eligible CDI Holders are encouraged to read the SPP booklet carefully, and if in any doubt about whether or not
to accept the SPP offer, to consult with a financial or other professional adviser.
The SPP offer is expected to close at 5.00pm (AEST) on Friday, 28 August 2026 (unless extended, withdrawn or
closed early by the Company). To apply for New CDIs, Eligible CDI Holders must, by 5.00pm (AEST) on Friday, 28
August 2026, make a payment directly via BPAY® in accordance with the instruc ons on their personalised
applica on form. Eligible CDI Holders with a registered address in New Zealand who are unable to pay by
BPAY® may pay for New CDIs by making an electronic funds transfer in accordance with the instruc ons on
their personalised applica on form.
CDI holders with ques ons in rela on to how to par cipate in the SPP should contact Peloton Shareholder
Services via email at Shareholder@pelshare.com.au or consult their financial or other professional adviser.
Key dates for the SPP
Event Date
SPP record date 7:00pm (AEST) Thursday, 2 July 2026
Opening Date for applications 9.00am (AEST) Friday, 7 August 2026
Closing Date for applications 5.00pm (AEST) Friday, 28 August 2026
Results of SPP announced Friday, 4 September 2026
Issue of SPP CDIs Friday, 4 September 2026
SPP CDIs commence trading on ASX Monday, 7 September 2026
Despatch of holding statements Tuesday, 8 September 2026
All dates and times refer to AEST. The timetable (and each reference in this announcement to a date specified in the
timetable) is indicative only. Enlitic may, at its discretion, vary any of the above dates by lodging a revised timetable with
the ASX.
ENDS
This announcement was authorised for release by the Board of Enlitic, Inc.
Enquiries
Enlitic Investor Relations
Australia:
invest_au@enlitic.com
Six Degrees Investor Relations
Henry Jordan
Henry.jordan@sdir.com.au
+61 431 271 538
About Enlitic
Enlitic is a software company that uses artificial intelligence to develop software products that
manage medical imaging data in radiology (such as MRI, CT scans, Xray and ultrasound images) and
licences such products to healthcare providers. Enlitic’s products (including its current product
offering and product suite under development) seek to standardise, protect, integrate, and analyse
data to create the foundation of a real-world evidence platform that can improve clinical workflows,
increase efficiencies, and expand capacity. Read more at enlitic.com.
Enlitic’s CDIs are traded on ASX in reliance on the safe harbour provisions of Regulation S under the
US Securities Act of 1933 as amended, and in accordance with the procedures established pursuant
to the provisions of a no action letter dated 7 January 2000 given to ASX by the staff at the US
Securities and Exchange Commission. The relief was given subject to certain procedures and
conditions described in the no action letter. One of the conditions is that the issuer provides
notification of the Regulation S status of its securities in communications such as this
announcement.
Forward-looking statements
Certain statements made during or in connection with this announcement contain or comprise
certain forward-looking statements regarding the Company, its projected cash flow, financial
performance, its customer contracts and customer pipeline and product development. Although the
Company believes that the expectations reflected in such forward-looking statements are
reasonable, such expectations are only predictions and are subject to inherent risks and
uncertainties which could cause actual values, results, performance or achievements to differ
materially from those expressed, implied or projected in any forward looking statements and no
assurance can be given that such expectations will prove to have been correct.
Accordingly, results could differ materially from those set out in the forward-looking statements as a
result of, among other factors, changes in economic and market conditions, delays or changes in
product development and realisation of customer pipeline, changes in demand, success of business
and operating initiatives, changes in the regulatory environment and other government actions,
fluctuations in exchange rates and business and operational risk management.
To the maximum extent permitted by law, each of the Company, its officers, employees and advisers
expressly disclaim any responsibility for the accuracy or completeness of the material contained in
these forward-looking statements and excludes all liability whatsoever (including in negligence) for
any loss or damage which may be suffered by any person as a consequence of any information in
forward-looking statements or any error or omission. The Company undertakes no obligation to
update publicly or release any revisions to these forward-looking statements to reflect events or
circumstances after today’s date or to reflect the occurrence of unanticipated events other than
required by the applicable laws, including the ASX Listing Rules. Accordingly, you should not place
undue reliance on any forward-looking statement.
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES
Enlitic, Inc.
Security Purchase Plan Booklet
This is an important document and requires your immediate attention. You should read this Booklet
in full.
Eligible CDI Holders have the opportunity to participate in the Security Purchase Plan offer by
applying for up to $30,000 worth of new CDIs without incurring brokerage or other transaction
costs. Details of the offer and how to participate are set out in this Booklet.
Applications for new CDIs under the SPP Offer must be received by 5.00pm (Melbourne
time) on Friday, 28 August 2026.
This Booklet is dated 7 August 2026.
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES
page 1
Table of contents
1 Letter to CDI Holders 1
2 Summary of important dates 4
3 Summary of SPP 5
4 SPP Terms and Conditions 10
4.1 Offer .................................................................................................................. 10
4.2 Eligible CDI Holders......................................................................................... 11
4.3 Joint holders and Custodians ........................................................................ 11
4.4 Applications for SPP CDIs.............................................................................. 11
4.5 Issue Price........................................................................................................ 13
4.6 Number of SPP CDIs to be issued ................................................................. 13
4.7 Issue of SPP CDIs............................................................................................ 14
4.8 CDI Holders outside Australia ........................................................................ 14
4.9 Representations, warranties and acknowledgements................................. 14
4.10 Scale back ........................................................................................................ 17
4.11 Dispute resolution ........................................................................................... 18
4.12 Variation and termination ............................................................................... 18
4.13 Privacy policy................................................................................................... 18
4.14 ASIC Corporations Instrument compliance .................................................. 19
4.15 Underwriting..................................................................................................... 19
4.16 Governing law .................................................................................................. 19
5 Glossary 20
Important information
This Booklet is intended for use only in connection with the SPP Offer to Eligible CDI
Holders. This Booklet does not constitute an offer of securities in any place outside
Australia or New Zealand and no action has been taken to permit an offering of CDIs in
any jurisdiction outside of Australia and New Zealand. The distribution of this Booklet may
be restricted by law and persons (including Custodians) who come into possession of this
document should observe any such restrictions. Due to legal restrictions, Custodians may
not distribute this Booklet or any other document relating to the SPP, and may not permit
any beneficial CDI Holder to participate in the SPP, in any country outside Australia or
New Zealand.
This Booklet may not be distributed or released in the United States (U.S.). This Booklet
does not constitute an offer to sell, or a solicitation of an offer to buy, any CDIs in the U.S.
or in any jurisdiction in which such an offer would be illegal. Enlitic’s CDIs are issued and
are traded on ASX in reliance on the safe harbour provisions of Regulation S under the
U.S. Securities Act of 1933, as amended (Securities Act), and in accordance with the
procedures established pursuant to the provisions of a no-action letter dated 7 January
2000 given to ASX by the staff at the U.S. Securities and Exchange Commission. The
CDIs to be offered and sold under the SPP Offer have not been, and will not be,
registered under the Securities Act, or the securities laws of any U.S. state or other
jurisdiction of the U.S., and may not be offered or sold, directly or indirectly, to persons in
the U.S. or to any person acting for the account or benefit of a person in the U.S. (to the
extent such person is acting for the account or benefit of a person in the U.S.) except
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES
page 2
pursuant to an exemption from the registration requirements of the Securities Act and
applicable state securities laws. Hedging transactions involving the securities described
in this Booklet may not be conducted unless in compliance with the Securities Act. The
relief was given subject to certain procedures and conditions described in the no-action
letter. One of the conditions is that Enlitic provides notification of the Regulation S status
of its securities in communications such as this document.
The SPP Offer is being made available to investors in reliance on the exemption from
registration contained in Regulation S of the Securities Act for offers of securities which
are made outside the United States. This means the CDIs issued in the SPP Offer are
subject to restrictions under Regulation S.
In order to comply with the requirements of Regulation S, investors may not resell any
SPP CDIs (or underlying securities) into the U.S. to a U.S. Person or for the account or
benefit of a U.S. Person for a period of one year after the date of issue of the securities
unless the resale of the securities is registered under the Securities Act or an exemption
from registration is available.
Accordingly, in order to enforce the above transfer restrictions whilst ensuring that
holders can still trade their CDIs on ASX, the CDIs will bear a “FOR US” designation on
ASX. As a result of the imposition of the “FOR US” designation, all securityholders of
Enlitic will be restricted from selling their CDIs on ASX to U.S. Persons.
The SPP Offer is not a recommendation to acquire CDIs. This document does not
constitute financial product advice and does not take into account the individual
investment objectives, financial situation or particular needs of each Eligible CDI Holder.
Eligible CDI Holders wanting to participate in the SPP should obtain independent advice
in relation to the taxation and other consequences of an investment under the SPP before
making a decision as to whether to participate in the SPP. A cooling-off regime does not
apply in relation to the acquisition of CDIs under the SPP.
This Booklet does not purport to include or summarise all information that an investor
should consider when making an investment decision, nor does it contain all information
which would be required in a prospectus, product disclosure statement or other
disclosure document prepared in accordance with the Corporations Act or any other
applicable law. This Booklet should be read in conjunction with Enlitic’s periodic and
continuous disclosure announcements lodged with the ASX which are available at
www.asx.com.au.
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES
page 1
1 Letter to CDI Holders
Dear CDI Holder
On Wednesday, 29 July 2026, Enlitic, Inc. (Enlitic or the Company) shareholders
approved, for the purposes of Listing Rule 7.1 and all other purposes, the issue of up to
250,000,000 shares of common stock (and corresponding CDIs) each at the Issue Price
to Eligible CDI Holders under a security purchase plan. On behalf of the directors of
Enlitic, I am pleased to offer you the opportunity to participate in the Enlitic Security
Purchase Plan (SPP), which allows Eligible CDI Holders to subscribe for up to $30,000
worth of new CDIs in Enlitic (SPP CDIs) without incurring brokerage or other transaction
costs.
The SPP aims to raise up to approximately $1 million and is not underwritten. The SPP
follows Enlitic’s successful conditional placement announced on Friday, 3 July 2026 and
approved by Enlitic shareholders on Wednesday, 29 July 2026, which raised
approximately $15 million (Placement).
The SPP CDIs are being offered at the Issue Price of the lower of:
A$0.004 (being the same offer price as that under the Placement)1; and
a 2.5% discount to the volume weighted average price of CDIs traded on ASX
during the five trading days up to the closing date of the SPP Offer, rounded to
the nearest A$0.001.
For completeness, following completion of the SPP, the Company is proposing to
undertake a 10-to-1 share consolidation (reverse share split), expected to take effect in
September 2026. A consolidation reduces the number of shares (and corresponding
CDIs) on issue such that if you held 10 CDIs, after the consolidation you will hold 1 CDI,
but, theoretically, that CDI should have the same value as 10 CDIs prior to the
consolidation. On its own, a consolidation does not change the value of your holding or
your proportional ownership.
Use of proceeds
The proceeds from the Placement will be used for continued commercialisation, scale-up
of sales and marketing, working capital and balance sheet support. For further
information, refer to the Company’s ASX announcement and Investor Presentation dated
3 July 2026.
The proceeds from the SPP will be used for general corporate and working capital
purposes and flexibility in implementing Enlitic’s strategic commercial objectives. For
further information, refer to the Company’s ASX announcement and Investor Presentation
dated 3 July 2026.
Further details about the Placement, including a summary of some of the key risks
associated with holding an investment in Enlitic, are included in Enlitic’s ASX
announcement and Investor Presentation released on Friday, 3 July 2026, which we
encourage you to read. You can view these ASX announcements at Enlitic’s website:
https://ir.enlitic.com/asx-announcements/.
1
Represents:
a 20.0% discount to the closing price of CDIs traded on 30 June 2026 being the last trading day
prior to the Company entering a two day trading halt to conduct the Placement;
a 21.1% discount to the 5-day VWAP of A$0.005 per CDI up to and including 30 June 2026 being
the last trading day prior to the Company entering a two day trading halt to conduct the Placement;
and
a 20.0% discount to the closing price of A$0.005 as at 31 July 2026.
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES
page 2
Participation in the SPP
Participation in the SPP is voluntary and open to all Eligible CDI Holders, being persons
who were registered holders of CDIs in Enlitic at 7.00pm (Melbourne time) on Thursday,
2 July 2026 (Record Date), with a registered address in either Australia or New Zealand
at that time as shown on the CDI Register (and who meet certain other eligibility criteria).
The SPP Offer is also being extended to Eligible CDI Holders who are Custodians to
participate in the SPP on behalf of certain Eligible Beneficiaries on the Terms and
Conditions set out in this Booklet.
Persons in the United States are not eligible to participate in the SPP. Similarly, persons
(including Custodians) who hold CDIs on behalf of persons who reside outside Australia
or New Zealand (including the United States) or are acting for the account or benefit of
persons in the United States, are not eligible to participate in the SPP on behalf of those
persons. For the avoidance of doubt, holders of Enlitic shares of common stock that have
not transmuted such stock to CDIs as of the Record Date are not eligible to participate in
the SPP with respect to such Enlitic shares of common stock.
Once issued, SPP CDIs will rank equally with existing CDIs in Enlitic.
The terms and conditions of the SPP are provided in this Booklet. We urge you to read
these materials in their entirety and seek your own financial and taxation advice in
relation to the SPP, before you decide whether to participate.
How to apply for SPP CDIs
To apply for SPP CDIs, please follow the instructions in your personalised Application
Form. Your personalised Application Form can be accessed via
https://events.miraqle.com/enl-offer.
In accordance with the instruction in your personalised Application Form, you must either:
make a payment directly via BPAY®2, which is the fastest and easiest way to
apply; or
if you are an Eligible CDI Holder with a registered address in New Zealand and
unable to pay by BPAY, you may pay for SPP CDIs by making an electronic
funds transfer (EFT).
Cheque, bank draft, money order and cash payments will not be accepted.
Eligible CDI Holders wishing to apply for SPP CDIs must ensure that their payment (and
Application Form(s) (as applicable)) is received by no later than 5.00pm (Melbourne
time) on Friday, 28 August 2026.
Questions and further information
This Booklet contains important information about the SPP to assist you in deciding
whether to participate in the SPP. You should read this Booklet carefully and in its
entirety before deciding whether to apply.
If you have any questions in relation to how to participate in the SPP, please contact
Peloton Shareholder Services via email at Shareholder@pelshare.com.au or consult your
financial or other professional adviser. If you have any questions in relation to whether an
investment in Enlitic through the SPP Offer is appropriate for you, please contact your
stockbroker, accountant or other professional adviser.
Thank you for your continued support of Enlitic.
2
Registered by BPAY Pty Ltd (ABN 69 079 137 518).
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES
Yours sincerely
Lawrence B. Gozlan
Chair
Enlitic, Inc.
page 3
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES
page 3
Yours sincerely
Lawrence B. Gozlan
Chair
Enlitic, Inc.
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES
page 4
2 Summary of important dates
Event Date
Record Date (the date that eligibility to participate in the SPP
was determined)
7.00pm (Melbourne time)
Thursday, 2 July 2026
Opening Date for applications 9.00am (Melbourne time)
Friday, 7 August 2026
Closing Date for applications 5.00pm (Melbourne time),
Friday, 28 August 2026
Results of SPP announced Friday, 4 September 2026
Issue of SPP CDIs Friday, 4 September 2026
SPP CDIs commence trading on ASX Monday, 7 September 2026
Despatch of holding statements Tuesday, 8 September 2026
This timetable is indicative only and subject to change. Enlitic reserves the right to alter the
dates above at its discretion, subject to the Listing Rules and Corporations Act. All references to
times in this Booklet are to Melbourne time.
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES
page 5
3 Summary of SPP
You should read this section in conjunction with the Terms and Conditions set out in
section 4 of this Booklet.
Key SPP details Summary
SPP Offer Eligible CDI Holders of Enlitic may subscribe for up to $30,000 worth of
SPP CDIs without brokerage or other transaction costs.
Purpose of the SPP The proceeds of the SPP will be used for general corporate and
working capital purposes and flexibility in implementing Enlitic’s
strategic commercial objectives as outlined above. For further
information, refer to the Company’s ASX announcement and Investor
Presentation dated 3 July 2026.
Voluntary participation Participation in the SPP is entirely voluntary.
Before you decide whether to participate in the SPP, Enlitic
recommends you seek independent financial advice from your
stockbroker, accountant or other professional adviser.
If you do not wish to participate in the SPP, no further action is
required on your part.
Issue Price of the SPP
CDIs
The Issue Price of the SPP CDIs is the lower of:
A$0.004 (being the same offer price as that under
the Placement) 3
; and
a 2.5% discount to the volume weighted average
price of CDIs traded on ASX during the five
trading days up to the closing date of the SPP
Offer, rounded to the nearest A$0.001.
There is a risk that the market price of CDIs may rise or fall between
the date of this Booklet and the time of issue of SPP CDIs under the
SPP Offer. This means that the price you pay for the SPP CDIs issued
to you may be less than or more than the market price of CDIs at the
date of this Booklet or the time of issue.
Your application is unconditional and may not be withdrawn even if the
market price of CDIs is less than the Issue Price.
3
Represents:
a 20.0% discount to the closing price of CDIs traded on 30 June 2026 being the last trading day
prior to the Company entering a two day trading halt to conduct the Placement;
a 21.1% discount to the 5-day VWAP of A$0.005 per CDI up to and including 30 June 2026 being
the last trading day prior to the Company entering a two day trading halt to conduct the Placement;
and
a 20.0% discount to the closing price of A$0.005 as at 31 July 2026.
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES 3 Summary of SPP
page 6
Key SPP details Summary
Eligible CDI Holders Eligible CDI Holders are eligible to participate in the SPP, being
persons who were registered holders of CDIs at 7.00pm (Melbourne
time) on Thursday, 2 July 2026 with a registered address in either
Australia or New Zealand at that time as shown on the CDI Register,
provided that such holders are not in the United States and are not
acting for the account or benefit of a person in the United States or, in
the event that such holders are acting for the account or benefit of a
person in the United States, such holders are not participating in the
SPP in respect of that person. For the avoidance of doubt, holders of
Enlitic shares of common stock that have not transmuted such stock to
CDIs as of the Record Date are not eligible to participate in the SPP
with respect to such Enlitic shares of common stock.
The SPP Offer is also being extended to Eligible CDI Holders who are
Custodians to participate in the SPP on behalf of Eligible Beneficiaries
on the Terms and Conditions provided in this Booklet. Custodians may
only distribute documents relating to the SPP to Eligible Beneficiaries.
In particular, due to legal restrictions, Custodians may not distribute
this Booklet or any other document relating to the SPP, and may not
permit any beneficial CDI Holder to participate in the SPP, in any
country outside Australia or New Zealand.
Non-renounceable and
non-transferable
The SPP Offer is non-renounceable and cannot be transferred.
Investment amount Eligible CDI Holders may apply for SPP CDIs in parcels valued at
$1,000, $2,500, $5,000, $7,500, $10,000, $12,500, $15,000, $20,000,
$25,000 or $30,000.
The number of SPP CDIs issued to an Eligible CDI Holder will be
rounded up to the nearest whole number after dividing the application
monies by the Issue Price. Enlitic may (in its absolute discretion)
decide to undertake a scale back of applications to the extent, and in
the manner, it sees fit.
How to apply Eligible CDI Holders wishing to apply for SPP CDIs may do so by
making payment via:
BPAY; or
EFT (available only for Eligible CDI Holders with a registered
address in New Zealand and unable to pay by BPAY).
Instructions about how to apply for SPP CDIs and make payment
(including your unique BPAY reference number) are contained in your
personalised Application Form which can be accessed via
https://events.miraqle.com/enl-offer. You will need to provide your
securityholder reference number (SRN) or holder identification number
(HIN) and follow the instructions provided. Your SRN or HIN can be
found on your holding statement and other securityholder
communications.
You can request a paper copy of this Booklet and your personalised
Application Form by contacting the CDI Registry from 8.30am to
5.00pm (Melbourne time) Monday to Friday (excluding public holidays)
NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES 3 Summary of SPP
page 7
Key SPP details Summary
on 1300 554 474 (for callers within Australia) or +61 1300 554 474 (for
callers outside Australia) during the Offer Period. To accept the SPP
Offer using these paper copy documents, you will still need to make
payment via BPAY or EFT.
You can only make payment via BPAY if you are the holder of an
account with an Australian branch of a financial institution that supports
BPAY transactions.
If you are an Eligible CDI Holder with a registered address in New
Zealand and are unable to pay by BPAY, your personalised Application
Form will contain instructions on how to pay via EFT. If you are paying
via EFT, you must return your personalised Application Form in
accordance with the instructions provided on your personalised
Application Form.
If you are paying via BPAY, there is no need to return your
personalised Application Form but you will be taken to have made the
statements and certifications that are set out in the Application Form4
.
Payment for SPP CDIs for the appropriate amount (and Application
Form(s) (as applicable)) must be received by the CDI Registry prior to
the close of t
Share your feedback
Discover